Global Patent Index - EP 3886805 A1

EP 3886805 A1 20211006 - AQUEOUS COMPOSITION, IN PARTICULAR FOR TREATING MUCOSA AND/OR WOUNDS

Title (en)

AQUEOUS COMPOSITION, IN PARTICULAR FOR TREATING MUCOSA AND/OR WOUNDS

Title (de)

WÄSSRIGE ZUSAMMENSETZUNG, INSBESONDERE ZUR BEHANDLUNG VON SCHLEIMHAUT UND/ODER WUNDEN

Title (fr)

COMPOSITION AQUEUSE, EN PARTICULIER POUR TRAITER UNE MUQUEUSE ET/OU DES PLAIES

Publication

EP 3886805 A1 20211006 (DE)

Application

EP 19795510 A 20191023

Priority

  • DE 102018220631 A 20181129
  • EP 2019078876 W 20191023

Abstract (en)

[origin: WO2020108881A1] The invention relates to an aqueous composition, in particular for treating wounds, having: a dihydrotriazine compound of the following general formula I, where R1 represents (i) a phenyl group or a phenylalkyl group, each of which is optionally substituted with 1 to 3 substituents, selected from a group consisting of the C1-6-alkoxy group, the hydroxy group, a halogen atom, the C1-6-alkyl halide group, the C1-6-alkyl group, a sulfonamido group and the C1-6-alkoxy halide group, (ii) a naphthyl group or a naphthyl alkyl group, (iii) a heterocyclic group, a heterocyclic alkyl group or a heterocyclic aminoalkyl group, (iv) an alkyl group with 1 to 16 carbon atoms or (v) a cycloalkyl group or a cycloalkyl-alkyl group, R1' represents a hydrogen atom, bonded with the nitrogen atom at position 1 or 3 of the dihydrotriazine ring, R2 and R3, independently of one another, represent a hydrogen atom or a methyl group, R4 represents an alkyl group with 7 to 16 carbon atoms, and the dashed line indicates that the position of a double bond is either between positions 1 and 2 or positions 2 and 3 of the dihydrotriazine ring; or having a tautomer of said composition, or a salt thereof, and a surfactant.

IPC 8 full level

A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 31/53 (2006.01); A61K 47/10 (2017.01); A61K 47/26 (2006.01); A61K 47/32 (2006.01); A61K 47/34 (2017.01)

CPC (source: EP KR US)

A61K 9/0014 (2013.01 - EP KR); A61K 9/006 (2013.01 - EP KR); A61K 9/06 (2013.01 - KR US); A61K 9/08 (2013.01 - EP KR US); A61K 31/53 (2013.01 - EP KR US); A61K 47/10 (2013.01 - EP KR US); A61K 47/14 (2013.01 - KR); A61K 47/18 (2013.01 - US); A61K 47/186 (2013.01 - KR US); A61K 47/26 (2013.01 - EP KR US); A61K 47/32 (2013.01 - EP KR); A61K 47/34 (2013.01 - EP); A61K 47/38 (2013.01 - US); A61P 17/02 (2018.01 - EP KR); A61P 31/00 (2018.01 - EP KR); A61P 43/00 (2018.01 - EP)

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

DOCDB simple family (publication)

WO 2020108881 A1 20200604; AU 2019389074 A1 20210527; CN 113271924 A 20210817; DE 102018220631 A1 20200604; EP 3886805 A1 20211006; JP 2022509289 A 20220120; JP 7545969 B2 20240905; KR 20210098440 A 20210810; US 2022000877 A1 20220106

DOCDB simple family (application)

EP 2019078876 W 20191023; AU 2019389074 A 20191023; CN 201980078953 A 20191023; DE 102018220631 A 20181129; EP 19795510 A 20191023; JP 2021531021 A 20191023; KR 20217014484 A 20191023; US 201917293131 A 20191023